Vital Farms (VITL) Q4 2025 earnings review
Supply Constraints Conquered, But Margins Set to Compress in FY26
Vital Farms closed FY25 on a high note, delivering 28.7% net revenue growth in Q4 as the company successfully scaled its supply chain to over 600 small farms. However, the forward-looking narrative took a notably bearish turn. Management explicitly lowered its FY26 revenue outlook compared to their December Investor Day, citing volatile macro order patterns in early 2026. Furthermore, FY26 Adjusted EBITDA guidance implies profit dollars will actually shrink slightly at the midpoint, breaking a multi-year margin expansion trend as the company pivots heavily into promotional spending. To help digest the guidance cut and impending negative free cash flow cycle, the Board authorized a new $100 million stock repurchase program.
🐂 Bull Case
After years of being supply-constrained, Vital Farms grew its network to 600+ farms. This allowed volume growth to drive $27.2M in new Q4 revenue, proving the brand can scale when product is actually on the shelf.
A newly authorized $100M share repurchase program signals significant board confidence in the intrinsic value of the company and provides a floor for the stock during a heavy CapEx investment cycle.
🐻 Bear Case
Guiding for ~$150M in incremental FY26 revenue but zero incremental EBITDA. The transition from 'building capacity' to 'market expansion' will require heavy promotional spending, erasing operating leverage.
Operating cash flow halved in FY25 due to massive inventory builds. With FY26 CapEx guided to $140-$150M and flat EBITDA, Vital Farms will consume significant cash this year.
⚖️ Verdict: 🔴
Bearish. While top-line momentum remains impressive, the company just told investors that buying further market penetration is going to cost their margins. The combination of an explicit guidance cut vs Investor Day, compressing FY26 margins, and collapsing operating cash flows outweighs the top-line beat.
Key Themes
FY26 Profitability Reversing as Promotional Spend Ramps
After expanding Adjusted EBITDA margin to 15.0% in FY25, management is guiding for a sharp reversal. The FY26 guidance of $105-$115M in Adjusted EBITDA on $900-$920M in sales implies a margin compression down to ~12.1% at the midpoint. Management attributes this to 'normal promotional spending to convert growing consumer awareness into increased household penetration,' indicating the era of constrained-supply pricing power is giving way to expensive customer acquisition.
Macro Volatility Forces Guidance Cut
In a rare admission of weakness, Vital Farms explicitly noted that the FY26 Net Revenue guidance of $900-$920M is 'lower than the initial outlook at the Investor Day in December.' Management blamed the current macroeconomic environment and 'volatility in order patterns so far in January and February.' While they view this as a short-term disruption, it marks the first material crack in previously bulletproof consumer demand.
Operating Cash Flow Collapses on Inventory Build
Despite Net Income increasing 24% YoY in FY25 to $66.3M, Net Cash Provided by Operating Activities plunged 48% YoY to $33.7M (down from $64.8M). This divergence was driven almost entirely by a massive $47.8M increase in Inventories and a $13.5M increase in Accounts Receivable. While rebuilding inventory was a stated goal after H1 supply constraints, the sheer magnitude of working capital consumption is a red flag.
Volume Driving the Top-Line Rebound
Q4 revenue grew 28.7% to $213.6M, driven predominantly by volume growth ($27.2M contribution) alongside price/mix benefits ($20.4M contribution). By expanding Egg Central Station and the farmer network to over 600 small farms, Vital Farms has successfully removed the bottlenecks that suppressed volume earlier in the year.
Capital Allocation Shift & Leadership Transition
The Board authorized a two-year, $100M stock repurchase program. This is a significant shift in capital allocation for a high-growth, high-CapEx food brand, likely intended to offset negative free cash flows and signal valuation confidence. Concurrently, Founder Matt O'Hayer is stepping down as Executive Chairperson, with CEO Russell Diez-Canseco assuming the combined role.
Other KPIs
Decelerating slightly from 37.9% in FY24. Despite favorable price/mix benefits throughout the year, the margin compressed as the company absorbed increased labor and overhead costs required to scale the business.
Exploded 181% YoY from $23.7 million at the end of FY24. While management warned in prior quarters that they needed to rebuild their egg supply from heavily depleted levels (target: 2-3 weeks of supply), this massive cash drain will need to be monitored to ensure it isn't masking slowing sell-through.
Grew 19% YoY, showing healthy leverage against 25.3% revenue growth. However, this leverage is expected to reverse in FY26 as marketing and promotional activities accelerate to acquire new customers.
Guidance
Decelerating. Implies 19% to 22% YoY growth, down from 25.3% in FY25. Explicitly stated as a reduction from the December Investor Day outlook due to January/February order volatility.
Reversing. The midpoint of $110M implies a 3.5% YoY decline compared to FY25's $114.0M, despite guiding for roughly $150M in additional sales. This highlights the steep cost of planned promotional spending to drive household penetration.
Accelerating sharply. Up from $82.0M in FY25 and $28.6M in FY24. This massive outlay is driven by the construction of Vital Crossroads in Seymour, Indiana. Combined with flat EBITDA, this guarantees deeply negative Free Cash Flow in FY26.
Key Questions
Details on the Guidance Cut
You mentioned the $900-$920M revenue guide is lower than the December Investor Day outlook due to 'volatility in order patterns' in Jan/Feb. Can you quantify the size of the cut and specify if this volatility is retailer destocking or a true slowdown in consumer takeaway?
Promotional Spend and Margin Structure
The FY26 EBITDA guidance implies adding ~$150M in revenue with zero incremental profit dollars due to promotional spending. Is this level of promo spend a permanent structural shift required to maintain 20%+ top-line growth, or a temporary one-year reset?
Funding the Buyback vs CapEx
With $140-$150M in planned CapEx and ~$110M in EBITDA, free cash flow will be significantly negative in FY26. How aggressively do you plan to utilize the new $100M share repurchase program in this cash-burning environment?
Inventory Normalization
Inventories increased by nearly $48M this year. Do you consider internal inventory levels fully normalized now, and should we expect working capital to be a source of cash in FY26?